In this webinar, CN Bio Senior Scientist Dr. Ovidiu Novac will discuss how a human liver microphysiological system (MPS), or Liver-on-a-chip, can be used to understand the causality and mechanistic aspects of drug-induced liver injury (DILI).
Senior Scientist
CN Bio
Watch this webinar to learn:
With safety concerns being the major cause for failures in phases 1/2 clinical trials, it’s essential to develop more predictive models within preclinical drug discovery to improve data translatability.
In this webinar, CN Bio Senior Scientist Dr. Ovidiu Novac will discuss how a human liver microphysiological system (MPS), or Liver-on-a-chip, can be used to understand the causality and mechanistic aspects of drug-induced liver injury (DILI).
Ovidiu will discuss how his team validated the MPS using a broad set of mild to severely hepatotoxic compounds and how the MPS delivered novel insights not previously seen in vitro.
Visit cn-bio.com for more information & news
332 Cambridge Science Park, Milton Road Cambridge, CB4 0WN
+44 (0) 1223 737941 | enquiries@cn-bio.com Privacy Policy | Terms | Sitemap
© 2022 CN Bio Innovations
Registered No. 06517359. VAT No. 978184563
For all the latst news visit our news section here
332 Cambridge Science Park, Milton Road Cambridge, CB4 0WN
+44 (0) 1223 737941 | enquiries@cn-bio.com Privacy Policy | Terms | Sitemap
© 2022 CN Bio Innovations
Registered No. 06517359. VAT No. 978184563